RxDoctor Payments Data

Joseph Sohn, MD

Orthopaedic Surgery of the Spine · Middletown, CTNPI 1225095425

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (28.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Globus Medical accounts for 69.2% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2020 at $14,566 and has fallen 75.8% since, to $3,526 in 2025.

$58,927in general payments, 2019–2025

Across 119 payments — averaging $495.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$41K
  • Stryker$11K
  • Innovasis Inc$3K
  • Alphatec Spine, Inc$2K
  • Biedermann Motech, Inc.$765
  • Precision Spine, Inc.$192
  • plus $861 from 14 others

What the payments were for

  • Royalty or licence$10,36818%
  • Consulting fees$16,60028%
  • Speaking & faculty fees$15,20026%
  • Travel & lodging$13,44623%
  • Food & beverage$3,3146%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$58,927 in reported general payments places this provider in the 65th percentile of 25 orthopaedic surgery of the spine providers in Connecticut.

See all orthopaedic surgery of the spine providers in Connecticut

Medicare billing

Part B allowed, 2024
$219,546
Medicare patients
347
Services billed
38,475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin99$822
Celecoxib41$402
Tizanidine Hcl46$376
Ibuprofen17$217
Meloxicam60$208
Methocarbamol16$126
Methylprednisolone13$96
Tramadol Hcl16$46

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Middletown

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →